A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction.
Rhodes JC, Kahn R, Bolcen S, Shang N, Chung Y, Farley MM, Britton AN, Moore AE, Thomas S, Nadle J, Amsden LB, Skarbinski J, VanWinden KR, Barnes M, Engesser K, Ferrieri P, Hansen AP, Harrison LH, Jeffrey L, Nyholm JL, O'Leary ST, Olson-Chen C, Rowlands JV, Seopaul SA, Thomas AR, Wrigley HHN, McGee L, Vishwanathan SA, Akhter F, Alston B, Jia LT, Li Y, Patel PY, Rivers J, Southwell JE, Tran T, Maniatis P, Schrag SJ. A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction. Nat Commun. 2025 Oct 23; 16(1):9381.